Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Phase 1/2 Study Evaluating Genetically Modified Autologous T Cells Expressing a TCR Recognizing a Cancer/Germline Antigen as Monotherapy or in Combination With Nivolumab in Patients With Recurrent and/or Refractory Solid Tumors
The study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid …
Refractory CancerRecurrent CancerSolid Tumor, Adult+1 more
Immatics US, Inc.NCT03686124
Phase 1
A Phase Ib/II Study of Pembrolizumab, Ibrutinib and Rituximab in Refractory/Relapsed Primary Central Nervous System Lymphoma (PCNSL)
This research study is evaluating a combination therapy of 3 drugs as possible treatments for recurrent primary central nervous system lymphoma (PCNSL). The t…
Primary Central Nervous System LymphomaRecurrent CancerRefractory Cancer+1 more
Dana-Farber Cancer InstituteNCT04421560